Table 2.
Oligonucleotide primers used in this study.
| Primer | Nucleotide sequence 5’-3’ | Application |
|---|---|---|
| E150–5Sal (for) | TTTTGTCGACCCTGTACCTTATTCT | Amplification of enhancer E and introduc- tion of SalI and BglII restriction sites |
| E150–5Bgl2 (rev) | TTTAGATCTATCCTTGCCTTAAGGC | |
| rs3753381-F | ATTTTTACAGAGTTCACAGCTTCCAGA | rs3753381(A) design |
| rs3753381-R | CTGTGAACTCTGTAAAAATGTTTACTTGGA | |
| S1enh7F | AGAAGAATTTGGGGGCAGAGAGGACT | Amplification of enhancer D and intro duction of SalI restriction site |
| S1enh7SalR (rev) | AAAAGTCGACCCGCCCTTTTTCATGAGTTAAAC | |
| for G RXRA | TACGGATTTATCAGCTTCCAGAAAA | mut RXR G design |
| rev G RXRA | AAGCTGATAAATCCGTAAAAATGT TTAC | |
| for A RXRA | TACAGATTTATCAGCTTCCAGAAAA | mut RXR A design |
| rev A RXRA | AGCTGATAAATCTGTAAAAATGT TTAC | |
| for G FOXO3 | CATTACAACGGAGTTCACAGCTT | mut FOX G design |
| rev G FOXO3 | CTCCGTTGTAATGTTTACTTGGATG | |
| for A FOXO3 | CATTACAACAGAGTTCACAGCTT | mut FOX A design |
| rev A FOXO3 | CTCTGTTGTAATGTTTACTTGGATG |